Meth-linked heart failure on the rise in US vets

Numbers of methamphetamine-linked heart failures have been on the rise for more than a decade, especially in U.S. veterans, according to a study presented at this year’s American Heart Association Scientific Sessions.

More than 4.7 percent of Americans admit to trying meth, a highly addictive stimulant, at least once in their lives, CNN reported. Past research has proven the drug has toxic effects on both the heart and the brain.

The study’s authors found the average meth user with heart failure was 61 years old—11 years younger than the typical heart failure patient. Statistically, patients with a past of methamphetamine abuse were younger, unemployed, prone to PTSD and depression and more likely to be homeless.

“Military veterans are an especially vulnerable population for developing mental health and substance use issues,” Harshal Kirane, director of addiction services at Staten Island University Hospital in New York, told CNN.

Kirane and study author Marin Nishimura said they’re still unsure of why meth-linked heart failure is on the rise in this particular group of patients.

“What’s certainly contributing to the current popularity is likely due to the fact that it can be synthesized in small-scale laboratories,” Nishimura said. “And sold at relatively low street prices.”

Read the full story from CNN here:

""

After graduating from Indiana University-Bloomington with a bachelor’s in journalism, Anicka joined TriMed’s Chicago team in 2017 covering cardiology. Close to her heart is long-form journalism, Pilot G-2 pens, dark chocolate and her dog Harper Lee.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.